![]()
|
|
||||||||
J. Biol. Chem., Vol. 255, Issue 19, 9067-9074, 10, 1980
W Levin, MK Buening, AW Wood, RL Chang, B Kedzierski, DR Thakker, DR Boyd, GS Gadaginamath, RN Armstrong, H Yagi, JM Karle, TJ Slaga, DM Jerina and AH Conney
The (+)- and (-)-enantiomers of benzo[a]pyrene 7,8-oxide are hydrated
stereospecifically at C-8 to (-)- and (+)-trans-7,8-dihydroxy-7,8-
dihydrobenzo[a]pyrene, respectively, by rat hepatic epoxide hydrolase. The
(-)-enantiomer of benzo[a]pyrene 7,8-oxide is metabolized by microsomal
epoxide hydrolase at a rate 3- to 4-fold greater than the (+)-enantiomer.
At low conversion of racemic substrate, however, benzo[a]pyrene 7,8-oxide
is metabolized to the dihydrodiol at a rate equal to that of the
(+)-enantiomer. An analysis of the enantiomeric composition of the
dihydrodiol formed from the racemic substrate revealed preferential
formation of (-)-trans-7,8-dihydroxy-7,8- dihydrobenzo-[a]pyrene. At low
substrate conversion (< 20% metabolism), the enantiomeric purity of the
dihydrodiol was much higher than at high substrate conversion (> 50%
metabolism). Similar results were obtained with microsomes from hamster,
rabbit, guinea pig, mouse, and human liver. These results indicate that
epoxide hydrolase has a higher affinity for (+)-benzo[a]pyrene 7,8-oxide
than for the (-)-enantiomer. The kinetics of hydration of (+)- and
(-)-benzo[a]pyrene 7,8-oxide by purified epoxide hydrolase in detergent
solution showed the (+)- and (- )-enantiomers to have apparent Km values of
1.7 and greater than or equal to 20 microM, respectively. Tumorigenicity
studies with benzo[a]pyrene 7,8-oxide on mouse skin and in newborn mice
revealed that (+)-benzo[a]pyrene 7,8-oxide, the metabolic precursor of the
more tumorigenic (-)-7,8-dihydrodiol, is significantly more tumorigenic
than the (-)-enantiomer. However, racemic benzo[a]pyrene 7,8-oxide was more
tumorigenic than either enantiomer alone, indicating an enantiomeric
synergism in the carcinogenicity of benzo[a]pyrene 7,8-oxide. The data are
discussed in relation to the complete sequence of metabolic pathways
leading to an ultimate carcinogen from benzo[a]pyrene.
An enantiomeric interaction in the metabolism and tumorigenicity of (+)- and (-)-benzo[a]pyrene 7,8-oxide
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. M. Jeffrey, M. J. Iatropoulos, and G. M. Williams Nasal Cytotoxic and Carcinogenic Activities of Systemically Distributed Organic Chemicals Toxicol Pathol, December 1, 2006; 34(7): 827 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, R. L. Chang, A. W. Wood, J. G. Xie, M. T. Huang, X. X. Cui, P. L. Kole, H. C. Sikka, S. K. Balani, A. H. Conney, et al. Tumorigenicity of racemic and optically pure bay region diol epoxides and other derivatives of the nitrogen heterocycle dibenz[a,h]acridine on mouse skin Carcinogenesis, June 1, 2001; 22(6): 951 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Chang, A. W. Wood, S. Kumar, R. E. Lehr, N. Shirai, D. M. Jerina, and A. H. Conney Tumorigenicity of four optically active bay-region 3,4-diol 1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine on mouse skin and in newborn mice Carcinogenesis, November 1, 2000; 21(11): 1997 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chary, C. M. Harris, T. M. Harris, and R. S. Lloyd Differential Tolerance to DNA Polymerization by HIV-1 Reverse Transcriptase on N6 Adenine C10R and C10S Benzo[a]pyrene-7,8-dihydrodiol 9,10-Epoxide-adducted Templates J. Biol. Chem., February 28, 1997; 272(9): 5805 - 5813. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |